Insight Molecular Diagnostics (IMDX) Shares Outstanding (2020 - 2025)
Historic Shares Outstanding for Insight Molecular Diagnostics (IMDX) over the last 6 years, with Q3 2025 value amounting to $28.6 million.
- Insight Molecular Diagnostics' Shares Outstanding rose 11403.47% to $28.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $28.6 million, marking a year-over-year increase of 11403.47%. This contributed to the annual value of $17.5 million for FY2024, which is 11126.98% up from last year.
- Insight Molecular Diagnostics' Shares Outstanding amounted to $28.6 million in Q3 2025, which was up 11403.47% from $28.6 million recorded in Q2 2025.
- Insight Molecular Diagnostics' Shares Outstanding's 5-year high stood at $92.2 million during Q3 2021, with a 5-year trough of $4.6 million in Q4 2021.
- Moreover, its 5-year median value for Shares Outstanding was $8.3 million (2024), whereas its average is $24.6 million.
- Its Shares Outstanding has fluctuated over the past 5 years, first surged by 13693588.05% in 2021, then tumbled by 9481.3% in 2022.
- Over the past 5 years, Insight Molecular Diagnostics' Shares Outstanding (Quarter) stood at $4.6 million in 2021, then increased by 28.62% to $5.9 million in 2022, then surged by 39.26% to $8.3 million in 2023, then soared by 111.27% to $17.5 million in 2024, then soared by 64.01% to $28.6 million in 2025.
- Its Shares Outstanding stands at $28.6 million for Q3 2025, versus $28.6 million for Q2 2025 and $28.6 million for Q1 2025.